MEDICARE PART B
Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015
-
- $19.99
-
- $19.99
Publisher Description
In 2015, Medicare spent about $26 billion on Part B drugs, including injectable drugs, and certain cancer drugs, which are typically administered in a physician's office or hospital outpatient department. GAO was asked to examine Medicare's share of the Part B drug market. This report describes Medicare's market share for high-expenditure Part B drugs paid based on ASP and the characteristics of those drugs...
GENRE
Business & Personal Finance
RELEASED
2018
February 3
LANGUAGE
EN
English
LENGTH
34
Pages
PUBLISHER
Hugues DUMONT
SELLER
Hugues DUMONT
SIZE
962.8
KB
Pharmaceutical Prices in the 21st Century
2014
Challenge of Access to Oncology Drugs in Canada
2009
Is Cost Containment Impacting Pharmaceutical Innovation?
2008
An Analysis of the Initial Adoption of FAS 141 and 142 in the Pharmaceutical Industry.
2006
How Hospitals Can Arm Themselves in the War on Waste (Hospitals)
2010
Is Health Care Ready for a Full Menu of Prices?(Special Report: Price Transparency)
2008